Transgenic Group (TSE:2342) Asset Turnover: 0.72 (As of Mar. 2026)


TSE:2342 Transgenic Group Inc TSE:2342
60 GF Score
Price 円220.00
GF Value 円257.54
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Asset Turnover?

Transgenic Group TSE:2342 +1.85% 60 Asset Turnover is 0.72 as of Mar. 2026. GuruFocus rates TSE:2342 with a GF Score™ of 60/100 and a GF Value™ of 円257.54 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Transgenic Group's Revenue for the six months ended in Mar. 2026 was 円6,950 Mil. Transgenic Group's Total Assets for the quarter that ended in Mar. 2026 was 円9,689 Mil. Therefore, Transgenic Group's Asset Turnover for the quarter that ended in Mar. 2026 was 0.72.

Asset Turnover is linked to ROE % through Du Pont Formula. Transgenic Group's annualized ROE % for the quarter that ended in Mar. 2026 was -4.46%. It is also linked to ROA % through Du Pont Formula. Transgenic Group's annualized ROA % for the quarter that ended in Mar. 2026 was -2.20%.


Transgenic Group  (TSE:2342) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Transgenic Group's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-213.628/4790.097
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-213.628 / 13899.144)*(13899.144 / 9688.748)*(9688.748/ 4790.097)
=Net Margin %*Asset Turnover*Equity Multiplier
=-1.54 %*1.4346*2.0227
=ROA %*Equity Multiplier
=-2.20 %*2.0227
=-4.46 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Transgenic Group's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=-213.628/9688.748
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-213.628 / 13899.144)*(13899.144 / 9688.748)
=Net Margin %*Asset Turnover
=-1.54 %*1.4346
=-2.20 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Transgenic Group Asset Turnover Related Terms


Transgenic Group Asset Turnover Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Asset Turnover Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.08 1.28 1.34 1.36

Transgenic Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.62 0.66 0.65 0.72

TSE:2342 vs VRTX, REGN, ALNY: Asset Turnover Comparison

For the Biotechnology subindustry, Transgenic Group's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgenic Group Asset Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Transgenic Group's Asset Turnover falls into.


TSE:2342
60GF Score
Transgenic Group Inc TSE:2342
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Transgenic Group's Asset Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2026 )/( (Total Assets (A: Mar. 2025 )+Total Assets (A: Mar. 2026 ))/ count )
=13174.425/( (9586.399+9735.359)/ 2 )
=13174.425/9660.879
=1.36

Transgenic Group's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=6949.572/( (9642.137+9735.359)/ 2 )
=6949.572/9688.748
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.72 mean?
Transgenic Group (TSE:2342) has a Asset Turnover of 0.72 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Transgenic Group and its competitors.
Is Transgenic Group's Asset Turnover too high?
Transgenic Group's current Asset Turnover is 0.72. Overall, Transgenic Group has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Asset Turnover compare to VRTX and REGN?
Transgenic Group's Asset Turnover of 0.72 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Biotechnology company?
A good Asset Turnover depends on the Biotechnology industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Transgenic Group and its competitors. Transgenic Group's current Asset Turnover is 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.54, compared to a current price of 円220.00 — trading 14.6% below its estimated fair value. The current Asset Turnover is 0.72. Transgenic Group's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Asset Turnover is 0.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円220.00 is trading 14.6% below its estimated GF Value™ of 円257.54. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

  • Asset Turnover: 0.72
  • GF Value™: 円257.54 vs. price of 円220.00 (14.6% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
60GF Score

Get the complete analysis for TSE:2342

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円220.00
Price
円257.54
GF Value